Item 1A. Risk Factors
ITEM
1A - RISK FACTORS
An
investment in our common stock involves a high degree of risk. You should carefully consider the summary of risk factors described below,
together with all of the other information included in this report, before making an investment decision. If any of the following risks
actually occur, our business, financial condition or results of operations could suffer. In that case, the trading price of our common
stock could decline, and you may lose all or part of your investment. You also should read the section entitled “Special Note Regarding
Forward Looking Statements” above for a discussion of what types of statements are forward-looking statements, as well as the significance
of such statements in the context of this report. The risk factors below do not address all the risks relating to securities, business
and operations, and financial condition.
17
Table of Contents
Risk
Factors Relating to Our Business
Our
independent registered public accounting firm has included an explanatory paragraph relating to our ability to continue as a going concern
in its report on our audited financial statements included in this report. Our audited financial statements at June 30, 2025 ,
and for the year then ended, were prepared assuming that we will continue as a going concern.
Management
has evaluated the Company’s expected cash requirements, including investments in additional sales and marketing, research and
development, capital expenditures and working capital requirements, and believes the Company’s existing cash and funding available
under the GBC Credit Facility, along with the forecasted gross margin, will not be sufficient to meet the Company’s
anticipated capital requirements to fund planned operations for the next twelve months following the filing date of this Annual Report
on Form 10-K.
The
report from our independent registered public accounting firm for the year ended June 30, 2025 includes an explanatory paragraph stating
that our current liquidity position and projected cash needs raise substantial doubt about our ability to continue as a going concern,
along with management’s assessment and strategies. The perception that we may not be able to continue as a going concern may make
it difficult for us to raise new funds and to operate our business due to concerns about our ability to meet our contractual obligations.
There is no assurance that sufficient financing will be available when needed or on reasonable terms to allow us to continue our operations.
Our ability to continue as a going concern is contingent upon, among other factors, the availability of the GBC Credit Facility or obtaining
alternate financing. We cannot provide any assurance that we will be able to raise additional capital. See Liquidity and Financial
Condition in Note 2 – Summary of Significant Accounting Policies to the audited consolidated financial statements for additional
information.
We
have a history of losses and negative working capital.
For
the fiscal years ended June 30, 2025 and 2024, we had net losses of $6.7 million and $8.3 million, respectively. We have historically
experienced net losses and until we generate sufficient revenue, we anticipate that we will continue to experience losses in the near
future.
As
of June 30, 2025 and 2024, we had a cash balance of $1.3 million and $0.6 million, respectively. We currently believe that our existing
cash balances, availability of our GBC credit facility, cash resources from operations and gross proceeds
from our recent private placement will not be sufficient to fund our existing and planned operations for the next twelve months. Until
such time as we generate sufficient cash to fund our operations, we will need additional capital to continue our operations thereafter.
We
have historically relied on equity financing, borrowings under short-term loans with related parties, credit facilities and/or cash
resources from operating activities to fund our operations. Specifically, we have relied heavily on a credit facility with GBC, and there
can be no assurance that we will be able to maintain this facility, obtain additional funds via a new facility or that funds will be
available on terms acceptable to us, if at all. Failure to maintain the GBC debt facility without a replacement facility would have material
adverse impact on our operations.
If
we were to access additional capital via an equity or equity-linked financing, such funding would result in dilution of the ownership
interests of our current stockholders. If funds are not available on acceptable terms, we may be required to curtail our operations or
take other actions to preserve our cash, which may have a material adverse effect on our future cash flows and results of operations.
We
have identified material weaknesses in our internal control over financial reporting. If we are unable to remediate these material weaknesses,
or if we identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls,
we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect our business
and stock price.
Based
on management’s evaluation of our disclosure controls and procedures as of June 30, 2025, we identified material weaknesses in
our internal controls over financial reporting. The material weaknesses were based on our ineffective oversight of our internal control
over financial reporting and lack of sufficient personnel resources with technical accounting expertise related to certain aspects of
the financial reporting process. While management intends to continue the use of third-party consultants
and technical accounting experts and to implement measures designed to improve our internal control over financial reporting to remediate
material weaknesses, there can be no assurance that these steps will be effective.
18
Table of Contents
We concluded that the previously issued audited consolidated financial statements as of and for the
fiscal year ended June 30, 2023 and the unaudited consolidated financial statements as of and for the quarters ended September 30, 2023,
December 31, 2023, and March 31, 2024, which were filed with the Securities and Exchange Commission (“SEC”) on September
21, 2023, November 9, 2023, February 8, 2024 and May 13, 2024, respectively, should no longer be relied upon because of errors in such
financial statements relating to the improper accounting for inventory. Our Annual Report on Form 10-K filed for the year ended June 30, 2024 included the restatement of those periods. As a part of this restatement
and evaluation process, we also discovered that:
(a)
the
Company’s original estimate of the overstatement of inventories had risen due to additional excess and obsolete inventory identified
related to inventory components not recorded at the lower of cost or net realizable value, as well as consigned inventory not reconciled
in a timely manner;
(b)
the
Company had not properly recognized revenue in the periods in which the related performance obligations had been satisfied for a
contract with a certain customer, and that the Company had improperly recorded accounts receivable pertaining to that contract as
a reduction to its accounts payable owed to that customer although the right of offset conditions under ASC 210-20 had not been met,
resulting in misstatements to revenues, accounts receivable and accounts payable;
(c)
the
Company had improperly recorded various inventory write downs to research and development expenses although such expenses did not
meet the classification criteria for research and development under ASC 730, resulting in an overstatement of research and development
expenses and a corresponding understatement of cost of sales;
(d)
the
Company had various clearing accounts that had not been reconciled in a timely manner, resulting in misstatements of accounts payable,
inventories and cost of sales;
(e)
the
Company had not included certain product warranty-related expenses within the proper periods in its calculation of its product warranty
reserve estimate, resulting in an understatement of accrued expenses, an understatement of accounts payable and an understatement
of cost of sales; and
(f)
the
Company erroneously presented non-cash debt issuance cost incurred in conjunction with credit facility arrangements as a non-cash
adjustment to reconcile net loss to net cash used in operating activities in the consolidated cash flow statements when such cost
should have been recognized as a change in other assets.
As a result, our Annual Report on Form 10-K filed for the year ended June 30, 2024 included the restatement of our audited consolidated financial statements for the fiscal years ended June 30, 2023 and 2022,
including all related unaudited consolidated interim financial statements within the fiscal years ended June 30, 2024, 2023 and 2022.
After
re-evaluation, the Company’s management concluded that considering the errors described above, this represents an additional
material weakness in the Company’s disclosure controls and procedures and the Company’s internal control over financial reporting.
The material weakness was based upon a lack of sufficiently designed controls over the prevention of fraud and possible management override
of controls. To address this material weakness, management plans to continue to devote significant effort and resources to the remediation
and improvement of the Company’s internal control over financial reporting. The design of any system of controls also is based
in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in
achieving its stated goals under all potential future conditions. Moreover, the effectiveness of our controls and procedures may be limited
by a variety of factors, including faulty human judgment and simple errors, omissions or mistakes; fraudulent action of an individual
or collusion of two or more people; inappropriate management override of procedures; and the possibility that any enhancements to controls
and procedures may still not be adequate to assure timely and accurate financial control. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if
any, have been detected, and there is a risk that material misstatements may not be prevented or detected on a timely basis by internal
control over financial reporting.
We
are committed to remediating our material weakness and have continued to remediate the identified material weaknesses
through additional processes and controls, including the timing of inventory audits, review of inventory for obsolescence and completeness
of data used to estimate warranty liability. We intend to continue to strengthen our internal processes and procedures until the identified
material weaknesses have been fully remediated. However, there can be no assurance as to when this material weakness will be remediated
or that additional material weaknesses will not arise in the future. If we are unable to maintain effective internal control over financial
reporting, our ability to record, process and report financial information in a timely manner and accurately could be adversely affected
and could result in a material misstatement in our financial statements, which could subject us to litigation or investigations, require
management resources, increase our expenses, negatively affect investor confidence in our financial statements and adversely impact the
trading price of our common stock.
19
Table of Contents
We
are not currently in compliance with the continued listing requirements for the Nasdaq Stock Market. If we fail to regain compliance
or to meet the continued listing requirements, our common stock may be delisted, which could affect the market price of our common stock,
negatively impact stockholders’ ability to sell shares and negatively impact our ability to access the capital markets.
On
January 31, 2025, we received a notice (the “Stockholders’ Equity Notice”) from the Nasdaq Stock Market (“Nasdaq”)
LLC notifying the Company that based on its stockholders’ equity of $194,000 as reported in its Form 10-K for the fiscal year ended
June 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum
of $2,500,000 in stockholders’ equity for continued listing on Nasdaq (the “Stockholders’ Equity Requirement”).
Under
the Nasdaq rules and pursuant to the Stockholders’ Equity Notice, we had until March 17, 2025 to submit to Nasdaq a plan to regain
compliance with the Stockholders’ Equity requirement. On March 17, 2025, we filed such plan with Nasdaq to regain compliance with
the Stockholders’ Equity requirement, including requesting an extension through July 30, 2025, which is 180 calendar days from
the date of the Stockholders’ Equity Notice to regain compliance of the Stockholders’ Equity Requirement. On July 31, 2025,
we received a determination letter from the Staff notifying us that based on our most recent disclosure, our stockholders’ equity
was a deficit of $4,372,000 as of March 31, 2025 and that the Staff had determined that we had not regained compliance with the Stockholders’
Equity Requirement. The Staff informed us that trading of our common stock would be suspended at the opening of business on August 11,
2025, unless we requested an appeal of the Staff’s determination to a Nasdaq Hearings Panel (the “Panel”).
On
August 7, 2025, we submitted such hearing request to the Panel, which request will stay suspension of our securities and the filing of
the Form 25-NSE pending the Panel’s decision. On September 15, 2025, we raised $5.0 million in capital through
a private placement of Company securities In addition, we have taken steps to reduce our cash burn rate through a reduction in force of
approximately 15% of our work force. We are also exploring additional avenues to raise equity capital in order to be in compliance with
Nasdaq’s continued listing requirements. There can be no assurance that the Panel will grant our request for continued listing or
stay the suspension of our securities.
On September 4, 2025, the Company made its presentation to the Panel. On September 16, 2025, the Panel determined to grant the Company an exception to demonstrate compliance with the
Stockholders’ Equity Requirement and granted the Company’s request for continued listing, which extension is subject to the
following: (1) the Company shall file a Form 10-K for the period ending June 30, 2025 on or before September 30, 2025, and (2), the Company
shall demonstrate compliance with the Stockholder’s Equity Requirement on or before October 31, 2025 through public disclosures
describing the transactions undertaken by the Company to achieve compliance and demonstrate long-term compliance. If we fail
to comply with the Nasdaq listing requirements and do not regain compliance, our common stock will be subject to delisting by Nasdaq.
In the event our common stock is delisted, our stock price and market liquidity of our stock will be adversely affected, which will impact
our ability to sell securities in the market. Further, delisting from Nasdaq could also have other negative effects, including potential
loss of confidence by partners, lenders, suppliers and employees.
There
can be no assurance that our common stock will continue to trade on Nasdaq or trade on the over-the counter markets or any public market
in the future. In the event our common stock is delisted, our stock price and market liquidity of our stock will be adversely affected
which will impact your ability to sell your securities in the market.
The U.S. government is currently
imposing increased tariffs on certain products imported into the U.S., which includes lithium-ion batteries and other component parts,
which may have an adverse impact on our future operating results.
The lithium-ion battery industry has been subjected to tariffs implemented
by the United States government on goods imported from China. Since all of our lithium-ion battery cells are manufactured in China, current
and potential tariffs on lithium-ion battery cells imported by us from China could increase our costs, require us to increase prices to our customers or, if we are
unable to do so, result in lower gross margins on the products sold by us. In April 2025, the U.S. government increased import tariffs
across a wide range of countries at various rates, including on product imports from almost all countries and individualized higher tariffs
on certain countries. Some of these tariff announcements have since been followed by announcements of limited exemptions and temporary
pauses. Based on the tariffs enacted and currently in effect, we anticipate incurring incremental tariff costs, additional costs that
we may incur on component parts for our battery backs, and costs as a result of import pauses on certain of our product imports and supply-chain
interruptions. The uncertain impacts of higher tariffs on global economies and corporate
cost structures have also led to order delays by customers. As a result of such developments, we are actively seeking alternative sourcing
arrangements. If we are unable to diversify our supply chain and reduce China sourcing,
we remain subject to substantial potential exposure to tariffs, which would have significant impacts on our cost structure and product
margins.
We also import a portion of our
raw materials and components from other countries that are subject to import tariffs imposed by the U.S. government. These tariff changes
and subsequent retaliatory actions have the potential to increase product costs for us. China has already imposed tariffs on a wide range
of American products in retaliation for the American tariffs on steel and aluminum. Any resulting escalation of trade tensions, including
any further escalation of “trade wars” with other countries, could have a significant adverse effect on world trade and the
world economy, lead to disruptions in our supply chain, and as such, adversely impact our results of operations.
At this time, we cannot predict
how such enacted tariffs will impact our business and operations. The imposed tariffs on components imported by us from China or additional
tariffs on other countries where we source components necessary for our products could have a material adverse effect on our business
and results of operations. In addition, any changes in tariffs or additional restrictions on various products may be announced with little
or no advance notice. The adoption and expansion of tariffs or other trade restrictions, increasing trade tensions, or other changes in
governmental policies related to tariffs, trade agreements, products or policies, are difficult to anticipate or predict, which makes
it difficult for us to operate optimally. If we are unable to navigate further changes in U.S. or international trade policy, it could
have a material adverse impact on our business and results of operations. We are closely monitoring potential changes in international
trade policy and actively assessing the potential impact of these and other trade policy changes on our business operations and financial
performance.
We
are dependent on one supplier in China for our battery cells, and the inability of this supplier to continue to deliver, or their refusal
to deliver, our battery cells at prices and volumes acceptable to us, or as a result of any supply chain disruption, would have a material
adverse effect on our business, prospects and operating results.
We
do not manufacture the battery cells used in our energy storage solutions. Our battery cells, which are an integral part of our energy
storage solutions, are sourced from a single manufacturer located in China. We have spent a great deal of time in developing and testing
our battery cells that we receive from our main supplier. Our operations are materially dependent upon the continued market acceptance
and quality of this manufacturer’s products and its ability to continue to manufacture products that are competitive and that comply
with laws relating to environmental and efficiency standards. We generally do not maintain long-term agreements with our current supplier
and the loss of this supplier could have a material adverse effect upon the Company’s business, operating results and financial
condition.
In the near term, this relationship with our primary manufacturer is a critical component in our business and operations. To date, we
have no qualified alternative sources for our battery cells although we research and assess cells from other suppliers on an ongoing basis.
We are currently actively assessing our options to diversify suppliers for our battery cells to lessen this concentration. However, qualifying
new battery cell suppliers may be time-consuming and costly. In addition, any new battery cell would also require us to obtain a new UL
listing, which could further extend the timeframe for introducing new products.
20
Table of Contents
In response to business uncertainties
resulting from tariffs and increased tariff levels imposed by the U.S. government on goods imported into the U.S, we temporarily paused imports from our supplier in China. The pause
was short-lived as both parties quickly agreed to modified terms. At this time, the modified terms have not materially affected the Company’s
operations and we expect to continue sourcing and importing our battery cells from this supplier. However, further escalation of tariffs
between the U.S. and China could have a material effect on our ability to cost-effectively source from our supplier in China, which could
materially affect our business and operations.
The
restatement of our previously issued financial statements has had a material adverse impact on us, including increased
costs, loss of investor confidence, the increased possibility of legal or administrative proceedings and non-compliance with the Nasdaq
listing rules.
In
connection with our previous financial restatements, we have become subject to a number of additional risks and uncertainties, including:
●
We
have incurred substantial unanticipated costs for accounting, legal and consultancy fees in connection with the restatements and
internal investigation;
●
The
SEC may institute a formal investigation of the Company’s financial statements. In such an event, investigation will divert
our management’s time and attention and cause us to incur substantial costs. These investigations can also lead to fines or
injunctions or orders with respect to future activities, as well as further substantial costs and diversion of management time and
attention;
●
Expenses
related to a final settlement in connection with a class action litigation against us, our former chief executive officer, Ronald F.
Dutt, and our former chief financial officer, Charles A. Scheiwe and any additional costs in connection with the court approval of
such settlement. In addition, we are also subject to other regulatory proceedings or actions which can be lengthy, time consuming
and disruptive to normal business operations and could cause us to incur significant defense costs, including costs associated with
the indemnification of our officers and directors, and could damage our reputation or adversely affect our stock price. Any adverse
ruling or unfavorable resolution in any legal or regulatory proceeding or action could have a material adverse effect on our
business, operating results, or financial condition. For additional information regarding certain of the matters in which we are
involved, see Item 3, “Legal Proceedings,” contained in Part I of this report.
We are subject to litigation and legal proceedings which could adversely
affect our business, financial condition, results of operations or cash flows.
We
are subject to lawsuits, legal proceedings and claims in the normal course of our business, which can be expensive, lengthy, and disruptive
to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict. We are currently the subject
of complaints alleging violations of various laws, including but not limited to certain employment lawsuits, which are further described under the heading “Legal Proceedings” elsewhere in this report,
and in the future could also be subject to other proceedings. These proceedings and any other regulatory proceedings or actions may be
time consuming, could cause us to incur significant defense costs and could damage our reputation or adversely affect our stock price.
Any adverse ruling or unfavorable resolution in any legal or regulatory proceeding or action could have a material adverse effect on
our business, operating results or financial condition. For additional information regarding certain of the matters in which we are involved,
see Item 3, “Legal Proceedings,” contained in Part I of this report.
21
Table of Contents
We
will need to raise additional capital or financing to continue to execute and expand our business.
We
expect that our existing cash, additional funding which we believe is available
under our GBC Credit Facility, funds from our private placement, which closed on September 15, 2025, and cash generated from our operations
will not be sufficient to meet our anticipated
capital resources and to fund our planned operations for the next twelve months (see Liquidity
and Financial Condition in Note 2 – Summary of Significant Accounting Policies to the audited consolidated financial
statements for additional information). Further, the use of such credit facilities remains subject to performance metrics, certain
restrictions and compliance with loan covenants. If we are unable to meet the conditions provided in the loan documents, these funds
will not be available to us. In addition, should there be any delays in the receipts of key component parts, due in part to supply
chain disruptions, our ability to fulfil the backlog of sales orders will be negatively impacted resulting in lower availability of
cash resources from operations. We may be required to access other forms of capital to support our expanded operations and execute
our business plan by issuing equity or convertible debt securities, or by entering into another form of structured financing or
strategic transaction. Our ability to access such forms of capital will be impacted by investor confidence in our business strategy
as well as market conditions In addition, our failure to timely file our annual report on form 10-K for the fiscal year ended June
30, 2024 and subsequent interim quarterly reports on Form 10-Q means that we currently are ineligible to use a
registration statement on Form S-3. We will not be eligible to use a registration statement on Form S-3 again until we have timely
filed all materials and reports required to be filed pursuant to Section 13, 14 or 15(d) of the Securities Exchange Act of 1934 for
a period of at least twelve (12) calendar months immediately preceding the filing of a new registration statement on Form S-3. The
inability to use a Form S-3 registration statement will limit our ability to raise capital through sales of our securities in a
timely and cost-efficient manner.
In
the event we are required to obtain additional funds, there is no guarantee that additional funds will be available on a timely basis
or on acceptable terms. To the extent that we raise additional funds by issuing equity or convertible debt securities, our stockholders
may experience additional dilution and such financing may involve restrictive covenants. Newly issued securities may include preferences,
superior voting rights, and the issuance of warrants or other convertible securities that will have additional dilutive effects. We cannot
assure that additional funds will be available when needed from any source or, if available, will be available on terms that are acceptable
to us. Further, we may incur substantial costs in pursuing future capital and/or financing. We may also be required to recognize non-cash
expenses in connection with certain securities we may issue, such as convertible notes and warrants, which will adversely impact our
financial condition and results of operations. Our ability to obtain needed financing may be impaired by such factors as the weakness
of capital markets, and the fact that we have not been profitable, which could impact the availability and cost of future financings.
If such funds are not available when required, management will be required to curtail investments in additional sales and marketing and
product development, which may have a material adverse effect on future cash flows and results of operations.
In
the event of default of the Revolving Note under the GBC Credit Facility, such default could adversely affect our
business, financial condition, results of operations or liquidity.
The
loans and other obligations of the Company under the GBC Credit Facility
are secured by substantially all of our tangible and intangible assets, including, without limitation, intellectual property, pursuant
to the terms of a Loan and Security Agreement with GBC dated July 28, 2023 (the “Agreement”) and an Intellectual Property
Security Agreement (the “IP Security Agreement”). The GBC Credit Facility is evidenced by a revolving note (the “Revolving
Note”), which maturity date was automatically extended to July 31, 2027 (the “Maturity Date”) upon the conversion of
all the outstanding obligations under the Cleveland Note into equity of the Company at the closing of the Private Placement on September
15, 2025. Provided that there is no event of default, the Maturity Date can automatically be extended for one (1) year period upon payment
of a renewal fee for each such extension in the amount of three-quarters of one percent (0.75%) of the Revolving Loan Commitment, which
fee will be due and payable on or before the applicable Maturity Date. The holder of the Revolving Note is entitled to all of the benefits
and security provided for in the Agreement. All Revolving Loans shall be repaid by the Borrower on the Maturity Date, unless payable sooner
pursuant to the provisions of the Agreement. As a secured party, upon an event of default, GBC will have a first priority right to the
collateral granted to them under the Agreement and IP Security Agreement, and we may lose our ownership interest in the assets pledged
as security interest. Events of default have occurred under the GBC Credit Facility associated with certain EBITDA requirements that were
not achieved for the three-month period ending April 30, 2024, May 31, 2024 and July 31, 2024, non-compliance with various representations,
financial covenants and non-financial covenants relating to our financial restatements under the Agreement. We have obtained waivers with
respect to such defaults, which each waive any failure of the Company to be in compliance with such representations, financial covenants
and non-financial covenants under the Agreement. We may need to seek waivers in the future and we cannot provide any assurance that such
waivers will be available should we not be in compliance with the terms of the GBC Credit Facility in the future. If we had not been able
to obtain such waivers, we would have had events of default under the GBC Credit Facility and GBC could terminate their commitments under
the facility and foreclose against substantially all our assets. We would likely be forced to seek bankruptcy protection and our investors
could lose the full value of their investment in our common stock. As such, a default and/or loss of our collateral will have a material
adverse effect on our operations, business and financial condition.
22
Table of Contents
Backlog
may not be indicative of future operating results.
Future
revenue for the Company can be influenced by order backlog. Backlog represents the dollar amount of revenues we expect to recognize in
the future from contracts awarded and in progress. Backlog substantially represents new orders. Backlog is not a measure defined by generally
accepted accounting principles and is not a measure of contract profitability. Our methodology for determining backlog may not be comparable
to methodologies used by other companies in determining their backlog amounts. The backlog values we disclose include anticipated revenues
associated with: (1) the original contract amounts; (2) change orders for which we have received written confirmations from the applicable
customers; (3) change orders for which we expect to receive confirmations in the ordinary course of business; and (4) claims that we
have made against customers. In addition, the timing of order placement, size, and customer delivery dates can create unusual fluctuations
in backlog.
We
include unapproved change orders for which we expect to receive confirmations in the ordinary course of business in backlog, generally
to the extent of the lesser of the amount management expects to recover or the associated costs incurred. Any revenue that would represent
profit associated with unapproved change orders is generally excluded from backlog until written confirmation is obtained from the applicable
customer. However, consideration is given to our history with the customer as well as the contractual basis under which we may be operating.
Accordingly, in certain cases based on our historical experience in resolving unapproved change orders with a customer, the associated
profit may be included in backlog. However, if an unapproved change order is under dispute or has been previously rejected by the customer,
the associated amount of revenue is treated as a claim.
For
amounts included in backlog that are attributable to claims, we include unapproved claims in backlog when we have a legal basis to do
so, consider collection to be probable and believe we can reliably estimate the ultimate value. Claims revenue is included in backlog
to the extent of the lesser of the amount management expects to recover or associated costs incurred.
Backlog
may not be indicative of future operating results, and projects in our backlog may be cancelled, modified or otherwise altered by customers.
Our ability to realize revenue from the current backlog is dependent on among other things, the delivery of key parts from our vendors
in a timely manner. We can provide no assurance as to the profitability of our contracts reflected in backlog.
Economic
conditions may adversely affect consumer spending and the overall general health of our customers, which, in turn, may adversely affect
our financial condition, results of operations and cash resources.
Uncertainty
about the current and future global economic conditions may cause our customers to defer purchases or cancel purchase orders for our
products in response to tighter credit, decreased cash availability and weakened consumer confidence. Our financial success is sensitive
to changes in general economic conditions, both globally and nationally. Recessionary economic cycles, higher interest borrowing rates,
higher fuel and other energy costs, inflation, increases in commodity prices, higher levels of unemployment, higher consumer debt levels,
higher tax rates and other changes in tax laws or other economic factors that may affect consumer spending or buying habits could continue
to adversely affect the demand for our products. If credit pressures or other financial difficulties result in insolvency for our customers,
it could adversely impact our financial results. There can be no assurances that government and consumer responses to the disruptions
in the financial markets will restore consumer confidence.
We
are dependent on a few customers for the majority of our net revenues, and our success depends on demand from OEMs and other users of
our battery products.
Historically
a majority of our product sales have been generated from a small number of OEMs and customers, including three customers who, on an aggregate
basis, made up 73% of our sales for the year ended June 30, 2025, and three customers who, on an aggregate basis, made up 78% of our
sales for the year ended June 30, 2024. As a result, our success depends on continued demand from this small group of customers and their
willingness to incorporate our battery products in their equipment. The loss of a significant customer would have an adverse effect on
our revenues. There is no assurance that we will be successful in our efforts to convince end users to accept our products. Our failure
to gain acceptance of our products could have a material adverse effect on our financial condition and results of operations.
Additionally,
OEMs, their dealers and battery distributors may be subject to changes in demand for their equipment which could significantly affect
our business, financial condition and results of operations.
23
Table of Contents
We
do not have long-term contracts with our customers.
We
do not have long-term contracts with our customers. Future agreements with respect to pricing, returns, promotions, among other things,
are subject to periodic negotiation with each customer. No assurance can be given that our customers will continue to do business with
us. The loss of any of our significant customers will have a material adverse effect on our business, results of operations, financial
condition and liquidity. In addition, the uncertainty of product orders can make it difficult to forecast our sales and allocate our
resources in a manner consistent with actual sales, and our expense levels are based in part on our expectations of future sales. If
our expectations regarding future sales are inaccurate, we may be unable to reduce costs in a timely manner to adjust for sales shortfalls.
Real
or perceived hazards associated with Lithium-ion battery technology may affect demand for our products.
Press
reports have highlighted situations in which lithium-ion batteries in automobiles and consumer products have caught fire or exploded.
In response, the use and transportation of lithium-ion batteries has been prohibited or restricted in certain circumstances. This publicity
has resulted in a public perception that lithium-ion batteries are dangerous and unpredictable. Although we believe our energy storage
solutions are safe, these perceived hazards may result in customer reluctance to adopt our lithium-ion based technology.
Our
products may experience quality problems from time to time that could result in negative publicity, litigation, product recalls and warranty
claims, which could result in decreased revenues and harm to our brands.
A failure of our battery modules could cause personal or property damages for which we would be potentially liable. Damage
to or the failure of our energy storage solutions to perform to customer specifications could result in unexpected warranty expenses
or result in a product recall, which would be time consuming and expensive. Such circumstances could result in negative publicity or
lawsuits filed against us related to the perceived quality of our products which could harm our brand and decrease demand for our products.
We
may be subject to product liability claims .
If
one of our products were to cause injury to someone or cause property damage, including as a result of product malfunctions, defects,
or improper installation, then we could be exposed to product liability claims. We could incur significant costs and liabilities if we
are sued and if damages are awarded against us. Further, any product liability claim we face could be expensive to defend and could divert
management’s attention. The successful assertion of a product liability claim against us could result in potentially significant
monetary damages, penalties or fines, subject us to adverse publicity, damage our reputation and competitive position, and adversely
affect sales of our products. In addition, product liability claims, injuries, defects, or other problems experienced by other companies
in the solar industry could lead to unfavorable market conditions for the industry as a whole, and may have an adverse effect on our
ability to attract new customers, thus harming our growth and financial performance. Although we carry product liability insurance, it
may be insufficient in amount to cover our claims.
24
Table of Contents
Increases
in costs, disruption of supply or shortage of raw materials, in particular lithium-ion phosphate cells, could harm our business.
We
may experience increases in the costs, or a sustained interruption in the supply or shortage, of raw materials. Any such cost increase
or supply interruption could materially negatively impact our business, prospects, financial condition and operating results. For instance,
we are exposed to multiple risks relating to price fluctuations for lithium-iron phosphate cells.
These
risks include:
●
the
inability or unwillingness of battery manufacturers to supply the number of lithium-iron phosphate cells required to support our
sales as demand for such rechargeable battery cells increases;
●
disruption
in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and
●
an
increase in the cost of raw materials, such as iron and phosphate, used in lithium-iron phosphate cells.
Our
success depends on our ability to develop new products and capabilities that respond to customer demand, industry trends or actions by
our competitors and failure to do so may cause us to lose our competitiveness in the battery industry and may cause our profits to decline.
Our
success will depend on our ability to develop new products and capabilities that respond to customer demand, industry trends or actions
by our competitors. There is no assurance that we will be able to successfully develop new products and capabilities that adequately
respond to these forces. In addition, changes in legislative, regulatory or industry requirements or in competitive technologies may
render certain of our products obsolete or less attractive. If we are unable to offer products and capabilities that satisfy customer
demand, respond adequately to changes in industry trends or legislative changes and maintain our competitive position in our markets,
our financial condition and results of operations would be materially and adversely affected .
The
research and development of new products and technologies is costly and time consuming, and there are no assurances that our research
and development efforts will be either successful or completed within anticipated timeframes, if at all. Our failure to technologically
evolve and/or develop new or enhanced products may cause us to lose competitiveness in the battery market. In addition, in order to compete
effectively in the renewable battery industry, we must be able to launch new products to meet our customers’ demands in a timely
manner. However, we cannot provide assurance that we will be able to install and certify any equipment needed to produce new products
in a timely manner, or that the transitioning of our manufacturing facility and resources to full production under any new product programs
will not impact production rates or other operational efficiency measures at our manufacturing facility. In addition, new product introductions
and applications are risky, and may suffer from a lack of market acceptance, delays in related product development and failure of new
products to operate properly. Any failure by us to successfully launch new products, or a failure by us to meet our customers criteria
in order to accept such products, could adversely affect our results.
Our
business will be adversely affected if we are unable to protect our intellectual property rights from unauthorized use or infringement
by third parties.
Any
failure to protect our intellectual proprietary rights could result in our competitors offering similar products, potentially resulting
in the loss of some of our competitive advantage and a decrease in our revenue, which would adversely affect our business, prospects,
financial condition and operating results. Our success depends, at least in part, on our ability to protect our core technology and intellectual
property. To accomplish this, we rely on a combination of patents, patent applications, trade secrets, including know-how, employee and
third-party nondisclosure agreements, copyright laws, trademarks, intellectual property licenses and other contractual rights to establish
and protect our proprietary rights in our technology.
25
Table of Contents
The
protections provided by patent laws will be important to our future opportunities. However, such patents and agreements and various other
measures we take to protect our intellectual property from use by others may not be effective for various reasons, including the following:
●
The
patents we have been granted may be challenged, invalidated or circumvented because of the pre-existence of similar patented or unpatented
intellectual property rights or for other reasons;
●
The
costs associated with enforcing patents, confidentiality and invention agreements or other intellectual property rights may make
aggressive enforcement impracticable; and
●
Existing
and future competitors may independently develop similar technology and/or duplicate our systems in a way that circumvents our patents.
Our
patent applications may not result in issued patents, which may have a material adverse effect on our ability to prevent others from
commercially exploiting products similar to ours.
We
cannot be certain that we are the first creator of inventions covered by pending patent applications or the first to file patent applications
on these inventions, nor can we be certain that our pending patent applications will result in issued patents or that any of our issued
patents will afford protection against a competitor. In addition, patent applications that we intend to file in foreign countries are
subject to laws, rules and procedures that differ from those of the United States, and thus we cannot be certain that foreign patent
applications related to issue United States patents will be issued. Furthermore, if these patent applications are issued, some foreign
countries provide significantly less effective patent enforcement than in the United States.
The
status of patents involves complex legal and factual questions and the breadth of claims allowed is uncertain. As a result, we cannot
be certain that the patent applications that we file will result in patents being issued, or that our patents and any patents that may
be issued to us in the near future will afford protection against competitors with similar technology. In addition, patents issued to
us may be infringed upon or designed around by others and others may obtain patents that we need to license or design around, either
of which would increase costs and may adversely affect our business, prospects, financial condition and operating results.
We
rely on trade secret protections through confidentiality agreements with our employees, customers and other parties; the breach of such
agreements could adversely affect our business and results of operations.
We
rely on trade secrets, which we seek to protect, in part, through confidentiality and non-disclosure agreements with our employees, customers
and other parties. There can be no assurance that these agreements will not be breached, that we would have adequate remedies for any
such breach or that our trade secrets will not otherwise become known to or independently developed by competitors. To the extent that
consultants, key employees or other third parties apply technological information independently developed by them or by others to our
proposed projects, disputes may arise as to the proprietary rights to such information that may not be resolved in our favor. We may
be involved from time to time in litigation to determine the enforceability, scope and validity of our proprietary rights. Any such litigation
could result in substantial cost and diversion of effort by our management and technical personnel.
Our
business depends substantially on the continuing efforts of the members of our senior management team and our business may be severely
disrupted if we lose their services or are unable to recruit qualified replacements in the event of departures.
We
believe that our success is largely dependent upon the continued service of the members of our senior management team, who are responsible
for who establishing our corporate strategies and focus, overseeing the execution of our business strategy and ensuring our continued
growth. Our continued success will depend on our ability to attract and retain a qualified and competent management team in order to
manage our existing operations and support our expansion plans. If any of the members of our senior management team are unable or unwilling
to continue in their present positions, we may not be able to replace them readily. Therefore, our business may be severely disrupted,
and we may incur additional expenses to recruit and retain their replacement. In addition, if any of the members of our senior management
team joins a competitor or forms a competing company, we may lose some of our customers.
26
Table of Contents
If
we are forced to implement workforce and other cost reductions, our staff resources will be stretched making our ability to comply
with legal and regulatory requirements as a public company difficult.
There
can be no assurance that our management team will be able to implement and affect programs and policies in an effective and timely
manner especially if subject to workforce and other cost reductions, that adequately respond to increased legal, regulatory
compliance and reporting requirements imposed by such laws and regulations. Our failure to comply with such laws and regulations
could lead to the imposition of fines and penalties and further result in the deterioration of our business.
Compliance
with changing regulations concerning corporate governance and public disclosure may result in additional expenses.
There
have been changing laws, regulations and standards relating to corporate governance and public disclosure, including the (Sarbanes-Oxley)
Act of 2002, new regulations promulgated by the SEC and rules promulgated by the national securities exchanges. These new or changed
laws, regulations and standards are subject to varying interpretations in many cases due to their lack of specificity, and, as a result,
their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies, which could result
in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance
practices. As a result, our efforts to comply with evolving laws, regulations and standards are likely to continue to result in increased
general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance
activities. Members of our Board of Directors and our chief executive officer and chief financial officer could face an increased risk
of personal liability in connection with the performance of their duties. As a result, we may have difficulty attracting and retaining
qualified directors and executive officers, which could harm our business. If the actions we take in our efforts to comply with new or
changed laws, regulations and standards differ from the actions intended by regulatory or governing bodies, we could be subject to liability
under applicable laws or our reputation may be harmed.
In
addition, Sarbanes-Oxley specifically requires, among other things, that we maintain effective internal controls for financial reporting
and disclosure of controls and procedures. In particular, we must perform system and process evaluation and testing of our internal controls
over financial reporting to allow management to report on the effectiveness of our internal controls over financial reporting, as required
by Section 404 of Sarbanes-Oxley. Our testing, or the subsequent testing by our independent registered public accounting firm, when required,
may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses. Our compliance with
Section 404 will require that we incur substantial accounting expense and expend significant management efforts. We currently do not
have an internal audit group, and we may need to hire additional accounting and financial staff with appropriate public company experience
and technical accounting knowledge. Moreover, if we are not able to comply with the requirements of Section 404 in a timely manner, or
if we or our independent registered public accounting firm identifies deficiencies in our internal controls over financial reporting
that are deemed to be material weaknesses, the market price of our stock could decline, and we could be subject to sanctions or investigations
by the SEC or other regulatory authorities, which would require additional financial and management resources.
We
may face significant costs relating to environmental regulations for the storage and shipment of our lithium-ion energy storage solutions.
Federal,
state, and local regulations impose significant environmental requirements on the manufacture, storage, transportation, and disposal
of various components of advanced energy storage systems. Although we believe that our operations are in material compliance with applicable
environmental regulations, there can be no assurance that changes in such laws and regulations will not impose costly compliance requirements
on us or otherwise subject us to future liabilities. Moreover, Federal, state, and local governments may enact additional regulations
relating to the manufacture, storage, transportation, and disposal of components of advanced energy storage systems. Compliance with
such additional regulations could require us to devote significant time and resources and could adversely affect demand for our products.
There can be no assurance that additional or modified regulations relating to the manufacture, storage, transportation, and disposal
of components of advanced energy systems will not be imposed.
27
Table of Contents
Natural
disasters, public health crises, political crises and other catastrophic events or other events outside of our control may damage our
sole facility or the facilities of third parties on which we depend, and could impact consumer spending.
Our
sole production facility is located in southern California near major geologic faults that have experienced earthquakes in the past.
An earthquake or other natural disaster or power shortages or outages could disrupt our operations or impair critical systems. Any of
these disruptions or other events outside of our control could affect our business negatively, harming our operating results. In addition,
if our sole facility, or the facilities of our suppliers, third-party service providers or customers, is affected by natural disasters,
such as earthquakes, tsunamis, power shortages or outages, floods or monsoons, public health crises, such as pandemics and epidemics,
political crises, such as terrorism, war, political instability or other conflict, or other events outside of our control, our business
and operating results could suffer. Moreover, these types of events could negatively impact consumer spending in the impacted regions
or, depending upon the severity, globally, which could adversely impact our operating results. Similar disasters occurring at our vendors’
manufacturing facilities could impact our reputation and our consumers’ perception of our brands.
Security
breaches, loss of data and other disruptions could compromise sensitive information related to our business, prevent us from accessing
critical information or expose us to liability, which could adversely affect our business and our reputation.
We
utilize information technology systems and networks to process, transmit and store electronic information in connection with our business
activities. As the use of digital technologies has increased, cyber incidents, including deliberate attacks and attempts to gain unauthorized
access to computer systems and networks and divert financial resources, have increased in frequency and sophistication. These threats
pose a risk to the security of our systems and networks and the confidentiality, availability and integrity of our data, all of which
are vital to our operations and business strategy. There can be no assurance we will succeed in preventing cyber-attacks or successfully
mitigating their effects.
Despite
implementing security measures, any of the internal computer systems belonging to us or our suppliers are vulnerable to damage from computer
viruses, unauthorized access, natural disasters, terrorism, war, and telecommunication and electrical failure. Any system failure, accident,
security breach or data breach that causes interruptions could result in a material disruption of our product development programs. Further,
our information technology and other internal infrastructure systems, including firewalls, servers, leased lines and connection to the
Internet, face the risk of systemic failure, which could disrupt our operations. If any disruption or security breach results in a loss
or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information, we may incur resulting
liability, and competitive position may be adversely affected, and the further development of our products may be delayed. Furthermore,
we may incur additional costs to remedy the damage caused by these disruptions or security breaches.
Risks
Related to Our Common Stock and Market
The
market price of our common stock could become volatile, or our trading volume become weak, either of which could lead to the price of
our stock being depressed at a time when you may want to sell.
Our
common stock is being traded on the Nasdaq Capital Market under the symbol “FLUX.” We cannot predict the extent to which
investor interest in our common stock will lead to the development of an active trading market on that stock exchange or any other exchange
in the future. An active market for our common stock may never develop. We cannot assure you that the volume of trading in shares of
our common stock will increase in the future. The trading price of our common stock has experienced volatility and is likely to continue
to be highly volatile in response to numerous factors which have been discussed in this Section 1A, and additional factors, many of which
are beyond our control, including, without limitation, the following:
●
Our
earnings releases, actual or anticipated changes in our earnings, fluctuations in our operating results or our failure to meet the
expectations of financial market analysts and investors;
●
Changes
in financial estimates by securities analysts, if any, who might cover our stock;
●
Speculation
about our business in the press or the investment community;
●
Significant
developments relating to our relationships with our customers or suppliers;
●
Stock
market price and volume fluctuations of other publicly traded companies and, in particular, those that are in our industry;
●
Customer
demand for our products;
28
Table of Contents
●
Investor
perceptions of our industry in general and our Company in particular;
●
General
economic conditions and trends;
●
Announcements
by us or our competitors of new products, significant acquisitions, strategic partnerships or divestitures;
●
Changes
in accounting standards, policies, guidance, interpretation or principles;
●
Loss
of external funding sources;
●
Sales
of our common stock, including sales by our directors, officers or significant stockholders; and
●
Additions
or departures of key personnel, including but not limited to our chief financial officer.
The
trading price and volume of our common stock may impact your ability to sell your shares of common stock, causing you to lose all or
part of your investment.
The
ownership of our stock is highly concentrated in one of our directors.
Michael
Johnson, our director and sole director of Esenjay Investments LLC, beneficially owns in excess of 25% of our outstanding common
stock on an as-converted basis, which includes common stock underlying options and warrants that were exercisable or convertible, or
which would become exercisable or convertible within 60 days. As a result of his ownership, Mr. Johnson and Esenjay are able to significantly influence all matters requiring stockholder approval,
including the election of directors and approval of significant corporate transactions. This concentration of ownership may also
have the effect of delaying or preventing a change in control.
We
do not intend to pay dividends on shares of our common stock for the foreseeable future.
We
have never declared or paid any cash dividends on shares of our common stock. We intend to retain any future earnings to fund the operation
and expansion of our business and, therefore, we do not anticipate paying cash dividends on shares of our common stock in the foreseeable
future.
We are not currently in
compliance with the continued listing requirements for the Nasdaq Stock Market. If we fail to regain compliance or to meet the continued
listing requirements, our common stock may be delisted, which could affect the market price of our common stock, hurt your ability to
sell your shares and negatively impact our ability to access the capital markets
We cannot assure you that we will
be able to comply with the corporate governance requirements, minimum bid price requirement and the other standards that we are required
to meet in order to maintain a listing of our common stock on the Nasdaq Capital Market. Our failure to meet these requirements may result
in our common stock being delisted from the Nasdaq Capital Market. There can be no assurance that our common stock will continue to trade
on the Nasdaq Capital Market or trade on the over-the counter markets or any public market in the future. In the event our common stock
is delisted, our stock price and market liquidity of our stock will be adversely affected which will impact your ability to sell your
securities in the market.
29
Table of Contents
Preferred
Stock may be issued under our Articles of Incorporation, which may have superior rights to our common stock.
Pursuant to our Second Amended and Restated Articles of Incorporation,
our board of directors have the authority to fix the rights and preferences of the preferred stock by resolution from time to time, without
requiring the vote of the holders of our common stock or preferred stock would, unless otherwise expressly required by the Articles, the
preferred stock designation creating any series of preferred Stock, or to the extent required by the Nevada Revised Statutes or Nasdaq
(“Required Approval”). The Board could authorize the issuance of preferred stock with voting or conversion rights that are
superior to the rights of holders of common stock and issuance of such preferred stock could dilute the voting power or rights of the
holders of common stock. As such, the issuance of any preferred stock could diminish the rights of holders of our common stock, or delay
or prevent a change of control of our Company and, therefore, could reduce the value of such common stock.
The issuance of shares
of our Series A Preferred Stock would reduce the voting power and dilute the ownership of holders of our common stock, and may
adversely affect the market price of our common stock.
On September 15, 2025, we completed the private placement of 258,144 Prefunded
Warrants to purchase up to 258,144 shares of our Series A Preferred Stock to certain accredited investors for gross proceeds of $5 million.
Upon the exercise of the Prefunded Warrants and issuance of the shares of Series A Preferred Stock, holders of the Series A Preferred
Stock will be entitled to vote as a single class with the holders of common stock on an as-if-converted-to-common-stock-basis based on
the greater of the (i) Conversion Price, or the (ii) Minimum Price as defined in Rule 5635(d) of the Nasdaq Listing Rules. Holders of
Series A Preferred Stock shall also have the right to vote as a separate class with respect to certain specified matters. In addition,
holders of our Series A Preferred Stock are entitled to receive cumulative cash dividends at an annual dividend rate of 8.0%, which may
be payable in kind or in cash at the option of the Company. The subsequent issuance of additional shares of Series A Preferred Stock through
the payment of dividends will reduce the relative voting power of the holders of our common stock.
With respect to payment of dividends and distribution of assets upon liquidation,
dissolution or winding up of the Company, whether voluntary or involuntary, all shares of Series A Preferred Stock rank senior to all
the common stock and any other class of securities that is specifically designated as junior to the Series A Preferred Stock (“Junior
Securities”). Holders of Series A Convertible Preferred Stock have the right to receive a liquidation preference entitling them
to be paid out of our assets available for distribution to stockholders before any payment may be made to holders of any other class or
series of capital stock, an amount equal to the purchase price per warrant to purchase Series A Preferred Stock paid for by the holders
of Series A Preferred Stock (adjusted for any stock splits, stock dividends, recapitalizations, or similar transaction with respect to
the Series A Preferred Stock) for each share of Series A Preferred Stock before any distribution or payment will be made to the holders
of any Junior Securities, and if the assets of the Company will be insufficient to pay in full such amounts, then the entire assets to
be distributed to the holders of shares of Series A Preferred Stock will be ratably distributed among such holders in accordance with
the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. Holders of shares of Series
A Preferred Stock will have conversion rights that are superior to the rights of holders of common stock which issuance could dilute the
voting power or rights of the holders of common stock, and anti-dilutive protection, which our holders of common stock do not and will
not have.
In addition, the conversion of the Series A Preferred Stock to our common
stock would dilute the ownership interest of existing holders of our common stock, and any sales in the public market of the common stock
issuable upon conversion of the Series A Preferred Stock could adversely affect prevailing market prices of our common stock. In connection
with the Purchase Agreement and the Private Placement, we entered into a registration rights agreement pursuant to which we agreed to
prepare and file a registration statement with the SEC covering the resale of a number of shares of common stock underlying the Series
A Preferred Stock and the Common Warrants issued pursuant to the Purchase Agreement. These registration rights would facilitate the resale
of such securities into the public market, and any such resale would increase the number of shares of our common stock available for public
trading. Sales by the investors in the Private Placement of a substantial number of shares of our common stock in the public market, or
the perception that such sales might occur, could have a material adverse effect on the price of our common stock.